We invite you to engage in an interactive roundtable led by EverythingALS consortia of Pharma partners, sensor companies, neurologists, data scientists, regulators and patients to help advance the discovery and implementation of ALS digital biomarkers in clinical trials through our collaborative efforts.
Joining our participatory roundtable, you will be the first to learn about our latest study results on ALS digital biomarkers as well as have the opportunity to hear why major pharmaceutical companies have joined the consortium to partner in EverythingALS research, which will be expanded to include analyzing data from wearables and smartphones.
As always, we approach each roundtable to encourage out-of-the-box thinking, and to kick it off, we have an exciting agenda! Take a look below.
This is an invite only event.
Hosts & Speakers
June 12, 2023 - 3:30PM ET I 12:30PM PT
4:30 pm-5:00 pm ET is a Closed session for Consortia Members only
Welcome and Consortia Updates
Indu Navar - CEO and Founder, EverythingALS
James Berry, MD - Neurologist at MGH
Keynote : Persons Living with ALS
Daniel L Doctoroff - Founder of TargetALS. Daniel was CEO & Founder of Sidewalk Labs, an Alphabet company and President & CEO of Bloomberg LP. Before that Daniel was New York City’s longest-serving Deputy Mayor for Economic Development and Rebuilding.
Raquel Norel - Researcher at IBM Digital Health
Innovation through Collaboration: Efforts at the National Academies to Advance Neuroscience and Accelerate Treatments for ALS
Sheena M. Posey Norris - Senior Program Officer, National Academies of Sciences, Engineering and Medicine
Open discussion & Next Steps